The Coronavirus Vaccine, cataloged under National Stock Number 6505-01-734-2820, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Novavax Inc Div Corporate. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-734-2820 |
| Primary Part Number | NDC80631-0207-10 |
| Item Name | Coronavirus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Novavax Inc Div Corporate |
| Status | ACTIVE |
| Primary Container Content Quantity | 0.5 MILLILITERS |
| Virus Strain | COVID-19 |
| Primary Container Type | SYRINGE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC80631-0207-10 PRIMARY | Novavax Inc Div Corporate (USA) |
| Reference | Meaning |
|---|---|
| 1708630 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM252091 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-734-2820 is a Coronavirus Vaccine, manufactured by Novavax Inc Div Corporate, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-734-2820 has 1 manufacturer part number on file: NDC80631-0207-10 (Novavax Inc Div Corporate).
Key specifications for NDC80631-0207-10: Primary Container Content Quantity: 0.5 MILLILITERS; Virus Strain: COVID-19; Primary Container Type: SYRINGE; Special Features: INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) IN INDIVIDUALS 65 YEARS OF AGE AND OLDER, OR 12 YEARS THROUGH 64 YEARS OF AGE AND OLDER, OR 12 YEARS THROUGH 64 YEARS OF AGE WITH AT LEAST ONE UNDERLYING CONDITION THAT PUTS THEM AT HIGH RISK FOR SEVERE OUTCOMES FROM COVID-19; FOR INTRAMUSCULAR USE; CARTON OF 10 SINGLE-DOSE PRE-FILLED SYRINGES, EACH SYRINGE CONTAINS 1 DOSE OF 0.5 ML; STORE IN A REFRIGERATOR AT 2C TO 8C (36F TO 46F). DO NOT FREEZE; STORE IN THE ORIGINAL CARTON TO PROTECT FROM LIGHT.; 2025-2026 FORMULA; CONTAINS NO PRESERVATIVE.. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.